World Journal of Gastroenterology最新文献

{"title":"Beyond the gluten-free diet: Innovations in celiac disease therapeutics.","authors":"Sara Massironi, Marianna Franchina, Alessandra Elvevi, Donatella Barisani","doi":"10.3748/wjg.v30.i38.4194","DOIUrl":"10.3748/wjg.v30.i38.4194","url":null,"abstract":"<p><p>Celiac disease (CD) is an autoimmune disorder exacerbated by the ingestion of gluten in genetically susceptible individuals, leading to intestinal inflammation and damage. This chronic disease affects approximately 1% of the world's population and is a growing health challenge due to its increasing prevalence. The development of CD is a complex interaction between genetic predispositions and environmental factors, especially gluten, culminating in a dysregulated immune response. The only effective treatment at present is a strict, lifelong gluten-free diet. However, adherence to this diet is challenging and often incomplete, so research into alternative therapies has intensified. Recent advances in understanding the molecular and immunological aspects of CD have spearheaded the development of novel pharmacologic strategies that should provide more effective and manageable treatment options. This review examines the latest innovations in CD therapies. The focus is on drugs in advanced clinical phases and targeting specific signaling pathways critical to the disease pathogenesis. We discuss both quantitative strategies such as enzymatic degradation of gluten, and qualitative approaches including immunomodulation and induction of gluten tolerance. Innovative treatments currently under investigation include transglutaminase inhibitors, which prevent the modification of gluten peptides, and nanoparticle-based therapies to recalibrate the immune response. These new therapies not only promise to improve patient outcomes but are also expected to improve quality of life by reducing the burden of dietary restrictions. The integration of these new therapies could revolutionize the treatment of CD and shift the paradigm from strict dietary restrictions to a more flexible and patient-friendly therapeutic approach. This review provides a comprehensive overview of the future prospects of CD treatment and emphasizes the importance of continued research and multidisciplinary collaboration to integrate these advances into standard clinical practice.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"30 38","pages":"4194-4210"},"PeriodicalIF":4.3,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525874/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Early gastric composite tumor comprising signet-ring cell carcinoma and mucosa-associated lymphoid tissue lymphoma: A case report.","authors":"Yi-Fan Jia, Fei-Fan Chen, Li Yang, Yun-Xia Ye, Yi-Zhu Gao, Wen-Yan Zhang, Jin-Lin Yang","doi":"10.3748/wjg.v30.i38.4232","DOIUrl":"10.3748/wjg.v30.i38.4232","url":null,"abstract":"<p><strong>Background: </strong>Composite tumors are neoplasms comprising two distinct, yet intermingling, cell populations. This paper reports a rare phenomenon where early gastric signet-ring cell carcinoma (SRCC) and gastric mucosa-associated lymphoid tissue (MALT) lymphoma coexist within the same lesion.</p><p><strong>Case summary: </strong>A 40-year-old woman presented to the West China Hospital for examination, which revealed a whitish, shallow, and uneven mucosal lesion in the stomach. The lesion was diagnosed as a poorly differentiated adenocarcinoma, including SRCC with atypical lymphoid hyperplasia associated with <i>Helicobacter pylori</i> infection, based on histopathological examination of the biopsy specimen. The lesion was excised using segmental gastrectomy. However, histological examination of the surgical specimen confirmed that it was a poorly differentiated gastric adenocarcinoma with features of SRCC and MALT lymphoma. These two entities were stage I and coexisted in the same lesion.</p><p><strong>Conclusion: </strong>It is uncommon for gastric SRCC and MALT lymphoma to coexist without distinct borders. Surgical resection is effective for these lesions.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"30 38","pages":"4232-4238"},"PeriodicalIF":4.3,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525871/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Review on article of preoperative prediction in chronic hepatitis B virus patients using spectral computed tomography and machine learning.","authors":"Yao-Qian Yuan, Qian-Qian Chen","doi":"10.3748/wjg.v30.i38.4239","DOIUrl":"10.3748/wjg.v30.i38.4239","url":null,"abstract":"<p><p>This letter comments on the article that developed and tested a machine learning model that predicts lymphovascular invasion/perineural invasion status by combining clinical indications and spectral computed tomography characteristics accurately. We review the research content, methodology, conclusions, strengths and weaknesses of the study, and introduce follow-up research to this work.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"30 38","pages":"4239-4241"},"PeriodicalIF":4.3,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525872/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Whole-volume histogram analysis of spectral-computed tomography iodine maps characterizes HER2 expression in gastric cancer.","authors":"Wei-Ling Zhang, Jing Sun, Rong-Fang Huang, Yi Zeng, Shu Chen, Xiao-Peng Wang, Jin-Hu Chen, Yun-Bin Chen, Chun-Su Zhu, Zai-Sheng Ye, You-Ping Xiao","doi":"10.3748/wjg.v30.i38.4211","DOIUrl":"10.3748/wjg.v30.i38.4211","url":null,"abstract":"<p><strong>Background: </strong>Although surgery remains the primary treatment for gastric cancer (GC), the identification of effective alternative treatments for individuals for whom surgery is unsuitable holds significance. HER2 overexpression occurs in approximately 15%-20% of advanced GC cases, directly affecting treatment-related decisions. Spectral-computed tomography (sCT) enables the quantification of material compositions, and sCT iodine concentration parameters have been demonstrated to be useful for the diagnosis of GC and prediction of its invasion depth, angiogenesis, and response to systemic chemotherapy. No existing report describes the prediction of GC HER2 status through histogram analysis based on sCT iodine maps (IMs).</p><p><strong>Aim: </strong>To investigate whether whole-volume histogram analysis of sCT IMs enables the prediction of the GC HER2 status.</p><p><strong>Methods: </strong>This study was performed with data from 101 patients with pathologically confirmed GC who underwent preoperative sCT examinations. Nineteen parameters were extracted <i>via</i> sCT IM histogram analysis: The minimum, maximum, mean, standard deviation, variance, coefficient of variation, skewness, kurtosis, entropy, percentiles (1^st, 5^th, 10^th, 25^th, 50^th, 75^th, 90^th, 95^th, and 99^th), and lesion volume. Spearman correlations of the parameters with the HER2 status and clinicopathological parameters were assessed. Receiver operating characteristic curves were used to evaluate the parameters' diagnostic performance.</p><p><strong>Results: </strong>Values for the histogram parameters of the maximum, mean, standard deviation, variance, entropy, and percentiles were significantly lower in the HER2+ group than in the HER2- group (all <i>P</i> < 0.05). The GC differentiation and Lauren classification correlated significantly with the HER2 status of tumor tissue (<i>P</i> = 0.001 and 0.023, respectively). The 99^th percentile had the largest area under the curve for GC HER2 status identification (0.740), with 76.2%, sensitivity, 65.0% specificity, and 67.3% accuracy. All sCT IM histogram parameters correlated positively with the GC HER2 status (<i>r</i> = 0.237-0.337, <i>P</i> = 0.001-0.017).</p><p><strong>Conclusion: </strong>Whole-lesion histogram parameters derived from sCT IM analysis, and especially the 99^th percentile, can serve as imaging biomarkers of HER2 overexpression in GC.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"30 38","pages":"4211-4220"},"PeriodicalIF":4.3,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525878/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anti-tumor efficacy of <i>Calculus bovis</i>: Suppressing liver cancer by targeting tumor-associated macrophages.","authors":"Ishita Kathuria, Bhupesh Singla","doi":"10.3748/wjg.v30.i38.4249","DOIUrl":"10.3748/wjg.v30.i38.4249","url":null,"abstract":"<p><p>Despite significant advances in our understanding of the molecular pathogenesis of liver cancer and the availability of novel pharmacotherapies, liver cancer remains the fourth leading cause of cancer-related mortality worldwide. Tumor relapse, resistance to current anti-cancer drugs, metastasis, and organ toxicity are the major challenges that prevent considerable improvements in patient survival and quality of life. <i>Calculus bovis</i> (CB), an ancient Chinese medicinal drug, has been used to treat various pathologies, including stroke, convulsion, epilepsy, pain, and cancer. In this editorial, we discuss the research findings recently published by Huang <i>et al</i> on the therapeutic effects of CB in inhibiting the development of liver cancer. Utilizing the comprehensive transcriptomic analyses, <i>in vitro</i> experiments, and <i>in vivo</i> studies, the authors demonstrated that CB treatment inhibits the tumor-promoting M2 phenotype of tumor-associated macrophages <i>via</i> downregulating Wnt pathway. While multiple studies have been performed to explore the molecular mechanisms regulated by CB<i>,</i> this study uniquely shows its role in modulating the M2 phenotype of macrophages present within the tumor microenvironment. This study opens new avenues of future investigations aimed at investigating this drug's efficacy in various mouse models including the effects of combination therapy, and against drug-resistant tumors.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"30 38","pages":"4249-4253"},"PeriodicalIF":4.3,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525873/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dual peroxisome proliferator-activated receptor α/δ agonists: Hope for the treatment of alcohol-associated liver disease?","authors":"Xin-Yang Zhang, Qin-Jun-Jie Chen, Feng Zhu, Min Li, Dan Shang","doi":"10.3748/wjg.v30.i37.4163","DOIUrl":"10.3748/wjg.v30.i37.4163","url":null,"abstract":"<p><p>In this letter, we review the article \"Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease\". We focus specifically on the detrimental effects of alcohol-associated liver disease (ALD) on human health. Given its insidious onset and increasing incidence, increasing awareness of ALD can contribute to reducing the prevalence of liver diseases. ALD comprises a spectrum of several different disorders, including liver steatosis, steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. The pathogenesis of ALD is exceedingly complex. Previous studies have shown that peroxisome proliferator-activated receptors (PPARs) regulate lipid metabolism, glucose homeostasis and inflammatory responses within the organism. Additionally, their dysfunction is a major contributor to the progression of ALD. Elafibranor is an oral, dual PPARα and δ agonist. The effectiveness of elafibranor in the treatment of ALD remains unclear. In this letter, we emphasize the harm of ALD and the burden it places on society. Furthermore, we summarize the clinical management of all stages of ALD and present new insights into its pathogenesis and potential therapeutic targets. Additionally, we discuss the mechanisms of action of PPARα and δ agonists, the significance of their antifibrotic effects on ALD and future research directions.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"30 37","pages":"4163-4167"},"PeriodicalIF":4.3,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142547841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recanalization of anastomotic occlusion following rectal cancer surgery using a rendezvous endoscopic technique with transillumination: A case report.","authors":"Jun Chi, Guang-Yu Luo, Hong-Bo Shan, Jun-Zhong Lin, Xiao-Jun Wu, Jian-Jun Li","doi":"10.3748/wjg.v30.i37.4149","DOIUrl":"https://doi.org/10.3748/wjg.v30.i37.4149","url":null,"abstract":"<p><strong>Background: </strong>Colorectal anastomotic occlusion is a serious complication of colorectal cancer surgery. Although several treatment strategies have been proposed, the management of anastomotic occlusion remains challenging. In this report, we present a case of anastomotic occlusion recanalization performed using a novel technique involving two endoscopes, one for radial incision and the other serving as a guide light. This novel technique offers significant advantages in terms of operational feasibility, reduced invasiveness, rapid recovery, and shortened hospital stay.</p><p><strong>Case summary: </strong>A 37-year-old man underwent low anterior resection and prophylactic double-lumen ileostomy for rectal cancer in June, 2023. Two months later, complete anastomotic occlusion was observed on colonoscopy. Therefore, we developed a novel atresia recanalization technique. Two endoscopes were placed, one through the colonic anastomosis and the other through the anus. A radial incision was successfully made from the colonic side, guided by the light of the endoscope from the anal side. Atresia recanalization was performed within 20 minutes. Three weeks after recanalization, colonoscopy revealed that the diameter of the colorectal anastomosis was approximately 16 mm and the patient therefore underwent stoma reversal in September. During the follow-up period of approximately one year, the patient remained well and no stenosis or obstruction symptoms were observed.</p><p><strong>Conclusion: </strong>Endoscopic atresia recanalization of colorectal anastomotic occlusion assisted by an opposing light source is safe and effective.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"30 37","pages":"4149-4155"},"PeriodicalIF":4.3,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142547846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Critical analysis of the effects of proton pump inhibitors on inflammatory bowel disease: An updated review.","authors":"Omesh Goyal, Manjeet Kumar Goyal","doi":"10.3748/wjg.v30.i37.4160","DOIUrl":"10.3748/wjg.v30.i37.4160","url":null,"abstract":"<p><p>This letter critically evaluates the effects of proton pump inhibitors (PPIs) on inflammatory bowel disease, particularly focusing on Crohn's disease (CD) and ulcerative colitis (UC), as discussed in Liang <i>et al</i>'s recent review. While the review provides significant insights, it relies heavily on cross-sectional and observational studies, which limits the ability to draw causal inferences. The heterogeneous study populations and inconsistent definitions of long-term PPI use further complicate the findings. This letter also highlights the need for rigorous control of confounding factors and considers the potential publication bias in the existing literature. The implications of these issues are discussed in the context of both CD and UC, and future research directions are proposed to address these shortcomings.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"30 37","pages":"4160-4162"},"PeriodicalIF":4.3,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514535/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142547839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Enhancing prognostic accuracy in predicting rectal neuroendocrine neoplasms.","authors":"Renin Peter Aa Raj, Abdulqadir J Nashwan","doi":"10.3748/wjg.v30.i37.4087","DOIUrl":"https://doi.org/10.3748/wjg.v30.i37.4087","url":null,"abstract":"<p><p>The recently published retrospective study introduces the GATIS score, a new predictive model for rectal neuroendocrine neoplasms. By analyzing data from a large Chinese multicenter cohort, the study shows that the GATIS score, incorporating tumor grade, T stage, tumor size, age, and prognostic nutritional index, demonstrates superior predictive power for overall survival and progression-free survival compared to traditional World Health Organization grade and tumor, nodes and metastases staging systems. This editorial aims to discuss the importance of the GATIS score, its potential impact on clinical practice, and the strengths and limitations of the study. Finally, it explores the significance, methodology, and clinical implications of these findings.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"30 37","pages":"4087-4089"},"PeriodicalIF":4.3,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514536/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142550093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating genetic insights into ulcerative colitis and anxiety: Limitations and future directions.","authors":"Ying Peng, Xi-Dai Long","doi":"10.3748/wjg.v30.i37.4156","DOIUrl":"10.3748/wjg.v30.i37.4156","url":null,"abstract":"<p><p>We reviewed the study by He <i>et al</i>, which investigates the genetic correlation between ulcerative colitis (UC) and anxiety using bidirectional Mendelian randomization. This study reveals a genetic link between UC and anxiety, diverging from prior research associating higher anxiety with Crohn's disease. While the study's use of large-scale genome-wide association studies data is commendable, it faces limitations such as single nucleotide polymorphism selection biases, lack of multiple testing corrections, and a reliance on European populations. Future research should address these limitations, incorporate diverse populations, and explore psychotherapeutic interventions to improve UC management and patient outcomes.</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"30 37","pages":"4156-4159"},"PeriodicalIF":4.3,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514530/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142550094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}